Holistic scores showed an increasing trend over time (day 0: 6.8 ± 7.0, 3 months: 7.2 ± 5.2, 12 months: 8.3 ± 5.0), with the majority of patients (57.1–72.7% across follow-up) meeting MCID in four or more PROMIS-29 domains.
← all excerpts
Objective, Same-Day SCS Trials with ECAP-Controlled Closed-Loop Therapy: Depth of Response is Maintained from Trial to 12 months.
1
—
—